• Recombinant Human Oncostatin M: Assay Workflows

  2026-08-28

  Build reproducible proliferation and cytokine-release experiments with a tag-free, low-endotoxin OSM preparation. This workflow also shows how rh-Oncostatin M can be evaluated as a controlled cytokine variable alongside lipid-remodeling and radioresistance assays without overstating what current evidence proves.

• Protease Inhibitors Rewire Light-Induced Stomatal Opening

  2026-08-28

  Wang and colleagues developed a chemical screen showing that selected protease inhibitors suppress blue-light-induced stomatal opening in Commelina benghalensis. The strongest compounds reduced phosphorylation of the guard-cell plasma-membrane H+-ATPase without disrupting phototropin activity or ABA responses, identifying protease inhibition as a useful route for dissecting unresolved signaling steps.

• Salvianolic acid B for Pulmonary Fibrosis

  2026-08-27

  Salvianolic acid B, also known as Dan Shen Suan B, gives fibrosis researchers a practical way to connect LH2 expression with collagen deposition, epithelial–mesenchymal transition, and matrix remodeling. This workflow emphasizes orthogonal readouts, fresh compound handling, and controls that separate antifibrotic signaling from nonspecific cytotoxicity.

• DIDS: A Stress-Test Tool for Metastasis Biology

  2026-08-27

  DIDS, or 4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid, is more than a chloride transport probe. This article explains how its broad pharmacology can be used—and carefully controlled—to dissect cell-death-associated prometastatic states, mitochondrial permeabilization, and cross-domain ion-channel biology.

• Erastin and the Final Phase of Ferroptosis

  2026-08-26

  Erastin is a ferroptosis inducer that exposes how redox collapse becomes irreversible plasma-membrane damage. This article connects Erastin assay design with new evidence on TMEM16F-mediated lipid scrambling, helping researchers distinguish pathway initiation from ferroptotic execution.

• SB743921: KSP Inhibitor Workflow Guide

  2026-08-26

  SB743921 combines subnanomolar KSP potency with kinesin selectivity, making it useful for separating mitotic arrest from downstream cell death. This workflow pairs dose–response testing with time-resolved viability and apoptosis measurements to improve interpretation across cancer cell lines and tumor xenograft models.

• 5-Methyl-CTP for Rational mRNA Design

  2026-08-25

  Explore how 5-Methyl-CTP can be evaluated as a 5-methyl modified cytidine triphosphate in mRNA synthesis, from transcript quality to delivery-aware assay design. This article connects nucleotide selection with the OMV-based vaccine platform reported in Advanced Materials.

• CREC Carbapenemase Gene Transmission in Guangdong

  2026-08-25

  Chen et al. integrate carbapenemase-gene localization, conjugative transfer, mobile-element analysis, and strain typing to examine carbapenem-resistant Enterobacter cloacae across eight Guangdong teaching hospitals. The findings indicate frequent plasmid-associated blaNDM−1 carriage, substantial transfer potential, and overlapping clonal lineages, providing a practical framework for hospital antibiotic resistance research.

• Phosphatase Inhibitor Cocktail 3: Practical Guide

  2026-08-24

  Phosphatase Inhibitor Cocktail 3 protects labile protein phosphorylation states during tissue and cultured-cell lysate preparation for phosphoprotein analysis. It is intended for sample-preparation workflows, not as a validated live-cell reagent or a universal substitute for assay-specific phosphatase controls.

• Prochlorperazine: D2 Antagonism to Melanoma

  2026-08-23

  Prochlorperazine is more than an established antiemetic: its dopamine D2 receptor antagonism, broader receptor pharmacology, and reported effects on melanoma cell viability, motility, MITF, and tyrosinase create a compelling translational research framework. This article interprets the anchor melanoma study, proposes disciplined validation workflows, and defines the limits of extending the compound into antiviral and cancer research.

• Recombinant Human Growth Hormone: Assay Workflows

  2026-08-22

  Build more reproducible growth hormone cell proliferation assays and mechanism-focused chondrocyte experiments with a defined recombinant ligand. This workflow connects dose-response testing to the IGFBP2–THBS1–IGF-1 axis while addressing reconstitution, controls, storage, and assay troubleshooting.

• SMAD3 Inhibition and ADAMTS-5 in Early OA

  2026-08-21

  Xiang et al. show that pharmacological inhibition of SMAD3 with SIS3 reduces ADAMTS-5 expression in early osteoarthritis cartilage, potentially through upregulation of miR-140. The combined cell and rat study provides a mechanistic framework for linking TGF-β signaling pathway activity with cartilage-degrading enzyme regulation, while also highlighting the importance of disease stage.

• EDC.HCl Coupling Workflow and QC Guide

  2026-08-21

  EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide synthesis, bioconjugation, and related in vitro workflows. It should be handled as a laboratory reagent only; the product dossier reports no in vivo or clinical data.

• Methicillin sodium salt: Reliable MSSA Assays

  2026-08-20

  A scenario-based guide to using Methicillin sodium salt (SKU C3238) in MSSA infection, viability, proliferation, and cytotoxicity workflows. It explains concentration selection, host-cell controls, MSSA-versus-MRSA interpretation, solution handling, and practical supplier-selection criteria.

• Cy3 NHS ester (non-sulfonated): Practical Protocol

  2026-08-20

  Cy3 NHS ester (non-sulfonated) provides a reactive orange fluorophore for covalent labeling of primary amines in proteins, peptides, oligonucleotides, and DNA. It is appropriate for workflows that tolerate DMSO or DMF, but it is not a suitable choice for aqueous-only labeling because the non-sulfonated dye is insoluble in water.

459 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page